A case of mycosis fungoides successfully treated with combination of bexarotene and mogamulizumab

Dermatol Ther. 2021 Mar;34(2):e14805. doi: 10.1111/dth.14805. Epub 2021 Jan 27.

Authors

Teruyoshi Hisamoto¹, Hiraku Suga¹, Yuki Kawana¹, Tomonori Oka¹, Tomomitsu Miyagaki², Makoto Sugaya³, Shinichi Sato¹

Affiliations

¹ Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
² Departments of Dermatology, St. Marianna University School of Medicine, Kawasaki, Japan.
³ Department of Dermatology, International University of Health and Welfare, Chiba, Japan.

PMID: 33486865
DOI: 10.1111/dth.14805

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Anticarcinogenic Agents*
Bexarotene / therapeutic use
Humans
Mycosis Fungoides* / drug therapy
Skin Neoplasms* / drug therapy
Tetrahydronaphthalenes

Substances

Antibodies, Monoclonal, Humanized
Anticarcinogenic Agents
Tetrahydronaphthalenes
Bexarotene
mogamulizumab